SuspendedNot applicableNCT04541381
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Studying Dihydropyrimidine dehydrogenase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Chicago
- Principal Investigator
- Peter H. O'Donnell, MDUniversity of Chicago
- Intervention
- Availability of clinical decision support based on pharmacogenomic results.(other)
- Enrollment
- 860 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2028
Study locations (1)
- University of Chicago Medical Center, Chicago, Illinois, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04541381 on ClinicalTrials.govOther trials for Dihydropyrimidine dehydrogenase deficiency
Additional recruiting or active studies for the same condition.
See all trials for Dihydropyrimidine dehydrogenase deficiency →